SCHEMBL4394070

SCHEMBL4394070

CN(C)S(=O)(=O)c1ccc(C(=N)NO)cc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.48
HSD17B10 Q99714 1/20 0.48
ALDH1A1 P00352 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 3/20 0.47
HTT P42858 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
TRPV4 Q9HBA0 1/20 0.46
GAA P10253 1/20 0.46
ATM Q13315 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TSHR P16473 1/20 0.44
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4394101 0.83 HTT (0.58) MAPTALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL4095461 0.79 ENPP2 (0.48)
SCHEMBL4397065 0.78 CASP3 (0.46) MAPTALDH1A1LMNAHTTL3MBTL1
SCHEMBL3552882 0.76 SMN1; SMN2 (0.52) ALDH1A1SMN1; SMN2LMNAHTTL3MBTL1
SCHEMBL312685 0.76 CA2 (0.60)
SCHEMBL6855109 0.76 SMN1; SMN2 (0.54) MAPTHSD17B10ALDH1A1SMN1; SMN2LMNA
SCHEMBL5249012 0.75 SMN1; SMN2 (0.57) MAPTHSD17B10ALDH1A1SMN1; SMN2LMNA
SCHEMBL14973311 0.73 TSHR (0.60) ALDH1A1SMN1; SMN2NPSR1TSHRPOLB
SCHEMBL5561006 0.73 SMN1; SMN2 (0.56) MAPTHSD17B10ALDH1A1SMN1; SMN2LMNA
SCHEMBL34672 0.73 ALDH1A1 (0.66) MAPTHSD17B10ALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1959951-B1 HETEROARYL SUBSTITUTED PIPERIDINE DERIVATIVES AS L-CPT1 INHIBITORS HOFFMANN LA ROCHE (CH) 2009-12-23 EP disclosed
CN-101321525-A Heteroaryl substituted piperidine derivatives as L-CPT1 inhibitors HOFFMANN LA ROCHE (CH) 2008-12-10 CN disclosed